Clinical Trial Update: Effect of Ashwagandha as Adjunct Therapy on BDNF and Cognitive Function in Schizophrenia Patients [NA]

View source ↗

Summary

A completed clinical trial evaluating Ashwagandha as an adjunct therapy to assess effects on BDNF levels and cognitive function in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Ashwagandha (Withania somnifera)

Snippet

Sponsor: Hasanuddin University | Conditions: Schizophrenia Patients | NA | Status: COMPLETED